Stephane Beilles

Title: The Innovations of Stephane Beilles

Introduction

Stephane Beilles is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of leishmaniasis. With a total of 2 patents to his name, Beilles continues to push the boundaries of medical innovation.

Latest Patents

Beilles' latest patents include groundbreaking work on dronedarone for use in leishmaniasis. The first patent focuses on formulations and associations that utilize dronedarone or its pharmaceutically acceptable salts for treating this disease. The second patent details a pharmaceutical composition and dosage form that includes dronedarone, aimed at improving oral administration. This composition is designed to limit the meal time effect following oral administration in humans, utilizing a lipid carrier to enhance the solubilization of the active principle and protect it from the negative effects of pH in the intestinal tract.

Career Highlights

Stephane Beilles is currently employed at Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to collaborate with other talented professionals in the field, contributing to innovative solutions in pharmaceuticals.

Collaborations

Some of his notable coworkers include Sandra Chambonnet and Jean-Pierre Collaveri. Their collective expertise enhances the research and development efforts at Sanofi.

Conclusion

Stephane Beilles exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the treatment of leishmaniasis, highlight the importance of research and collaboration in advancing medical science.